A.P. Pharma, Inc. (NASDAQOTCBB:APPA)

CAPS Rating: 1 out of 5

A specialty pharmaceutical company focused on developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology.

Results 1 - 3 of 3

Recs

0
Member Avatar pisspoorpicks (< 20) Submitted: 2/20/2013 1:44:48 AM : Outperform Start Price: $0.74 APPA Score: -52.51

03/27/2013 PDUFA of APF530 for prevention of acute and delayed onset chemotherapy induced nausea and vomiting.

Report this Post Reply

Recs

0
Member Avatar z1on (< 20) Submitted: 1/1/2013 10:45:48 PM : Outperform Start Price: $0.58 APPA Score: -41.63

Biotech mover and shaker

Report this Post Reply

Recs

0
Member Avatar import2udirect (< 20) Submitted: 8/27/2012 10:00:27 AM : Outperform Start Price: $0.76 APPA Score: -62.40

BB feels strong about it and if he feels strong hes usually right

Report this Post Reply
Results 1 - 3 of 3

Featured Broker Partners


Advertisement